In a move that has ignited considerable debate, the government’s proposal to reclassify marijuana as a less dangerous drug has drawn sharp criticism from the medical community. The Drug Enforcement Agency (DEA)’s intention to shift marijuana from a Schedule I to a Schedule III substance, aligning it with medications such as Tylenol and steroids, has sparked concerns among health professionals about the potential for public misunderstanding regarding the safety of cannabis.

Experts have raised alarms over the serious health risks associated with marijuana use, including addiction, heart disease, and severe psychiatric disorders. A key point of contention lies in the potency of modern marijuana strains. Current varieties exhibit THC levels averaging 13-15 percent, a significant increase from the two to four percent found in marijuana from the 1970s. Such high potency is linked to an elevated risk of psychosis and substantial psychological distress among regular users.

The physical health implications of cannabis use are also under scrutiny. Research indicates a correlation between any form of cannabis consumption and a higher incidence of adverse cardiovascular outcomes, such as heart attacks and strokes. Older adults, in particular, face an increased risk of heart failure associated with marijuana usage.

Despite the DEA’s assertion that marijuana overdoses do not result in annual fatalities, hospital admissions related to cannabis use considerably exceed those for drugs like MDMA (ecstasy). The mental health ramifications are equally concerning, with evidence suggesting an amplified risk of major depression and bipolar disorder among frequent cannabis consumers.

The potential reclassification of marijuana raises fears of underestimating these risks, especially given the significant rates of addiction observed, particularly among young users and those consuming high-potency strains. Experts stress the necessity of more comprehensive clinical data to thoroughly evaluate the hazards, benefits, and alternatives to cannabis use.

While some argue that downgrading marijuana could promote further research and clarify its medical advantages and drawbacks, the call for caution remains loud and clear. More evidence is essential to ensure informed decisions regarding marijuana consumption and to safeguard individuals from its detrimental effects.

As discussions around marijuana’s legal status continue, the emphasis on informed choice and the urgent need for additional investigation into cannabis’s impacts becomes increasingly paramount.

Source: Daily Mail